APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perennial Allergic Rhinitis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Perennial Allergic Rhinitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchPerennial Allergic Rhinitis Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Perennial Allergic Rhinitis Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Perennial Allergic Rhinitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perennial Allergic Rhinitis Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Perennial Allergic Rhinitis Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Perennial Allergic Rhinitis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Perennial Allergic Rhinitis Drug include Merck & Co., Inc., Pfizer Inc., VentiRx Pharmaceuticals, Inc., Shionogi & Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Glenmark Pharmaceuticals Ltd. and Faes Farma, S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Perennial Allergic Rhinitis Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Perennial Allergic Rhinitis Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Perennial Allergic Rhinitis Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Perennial Allergic Rhinitis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Perennial Allergic Rhinitis Drug Segment by Company

Merck & Co., Inc.

Pfizer Inc.

VentiRx Pharmaceuticals, Inc.

Shionogi & Co., Ltd.

Hisamitsu Pharmaceutical Co., Inc.

Glenmark Pharmaceuticals Ltd.

Faes Farma, S.A.

Perennial Allergic Rhinitis Drug Segment by Type

APC-3000

Bilastine

Desloratadine

Asapiprant

Others

Perennial Allergic Rhinitis Drug Segment by Application

Clinic

Hospital

Others

Perennial Allergic Rhinitis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perennial Allergic Rhinitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perennial Allergic Rhinitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perennial Allergic Rhinitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Perennial Allergic Rhinitis Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Perennial Allergic Rhinitis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Perennial Allergic Rhinitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Perennial Allergic Rhinitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Perennial Allergic Rhinitis Drug Industry Trends Table 2. Perennial Allergic Rhinitis Drug Industry Drivers Table 3. Perennial Allergic Rhinitis Drug Industry Opportunities and Challenges Table 4. Perennial Allergic Rhinitis Drug Industry Restraints Table 5. Global Perennial Allergic Rhinitis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Perennial Allergic Rhinitis Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Perennial Allergic Rhinitis Drug Sales Market Share by Manufacturers Table 9. Global Perennial Allergic Rhinitis Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Perennial Allergic Rhinitis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Perennial Allergic Rhinitis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Perennial Allergic Rhinitis Drug Manufacturers, Product Type & Application Table 13. Global Perennial Allergic Rhinitis Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Perennial Allergic Rhinitis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of APC-3000 Table 17. Major Manufacturers of Bilastine Table 18. Major Manufacturers of Desloratadine Table 19. Major Manufacturers of Asapiprant Table 20. Major Manufacturers of Others Table 21. Global Perennial Allergic Rhinitis Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2026) & (K Units) Table 23. Global Perennial Allergic Rhinitis Drug Sales by Type (2027-2032) & (K Units) Table 24. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type (2021-2026) Table 25. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type (2027-2032) Table 26. Global Perennial Allergic Rhinitis Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Perennial Allergic Rhinitis Drug Revenue by Type (2021-2026) & (K Units) Table 28. Global Perennial Allergic Rhinitis Drug Revenue by Type (2027-2032) & (K Units) Table 29. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type (2021-2026) Table 30. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Others Table 34. Global Perennial Allergic Rhinitis Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2026) & (K Units) Table 36. Global Perennial Allergic Rhinitis Drug Sales by Application (2027-2032) & (K Units) Table 37. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application (2021-2026) Table 38. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application (2027-2032) Table 39. Global Perennial Allergic Rhinitis Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Perennial Allergic Rhinitis Drug Revenue by Application (2021-2026) & (K Units) Table 41. Global Perennial Allergic Rhinitis Drug Revenue by Application (2027-2032) & (K Units) Table 42. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application (2021-2026) Table 43. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application (2027-2032) Table 44. Global Perennial Allergic Rhinitis Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Perennial Allergic Rhinitis Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Perennial Allergic Rhinitis Drug Sales Market Share by Region (2021-2026) Table 47. Global Perennial Allergic Rhinitis Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Perennial Allergic Rhinitis Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 51. North America Perennial Allergic Rhinitis Drug Sales by Country (2027-2032) & (K Units) Table 52. Europe Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 54. Europe Perennial Allergic Rhinitis Drug Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Perennial Allergic Rhinitis Drug Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Perennial Allergic Rhinitis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Perennial Allergic Rhinitis Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Perennial Allergic Rhinitis Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Region (2021-2026) Table 65. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Region (2027-2032) Table 66. Merck & Co., Inc. Company Information Table 67. Merck & Co., Inc. Business Overview Table 68. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Merck & Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 70. Merck & Co., Inc. Recent Development Table 71. Pfizer Inc. Company Information Table 72. Pfizer Inc. Business Overview Table 73. Pfizer Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 75. Pfizer Inc. Recent Development Table 76. VentiRx Pharmaceuticals, Inc. Company Information Table 77. VentiRx Pharmaceuticals, Inc. Business Overview Table 78. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 80. VentiRx Pharmaceuticals, Inc. Recent Development Table 81. Shionogi & Co., Ltd. Company Information Table 82. Shionogi & Co., Ltd. Business Overview Table 83. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Product Portfolio Table 85. Shionogi & Co., Ltd. Recent Development Table 86. Hisamitsu Pharmaceutical Co., Inc. Company Information Table 87. Hisamitsu Pharmaceutical Co., Inc. Business Overview Table 88. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio Table 90. Hisamitsu Pharmaceutical Co., Inc. Recent Development Table 91. Glenmark Pharmaceuticals Ltd. Company Information Table 92. Glenmark Pharmaceuticals Ltd. Business Overview Table 93. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Product Portfolio Table 95. Glenmark Pharmaceuticals Ltd. Recent Development Table 96. Faes Farma, S.A. Company Information Table 97. Faes Farma, S.A. Business Overview Table 98. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Faes Farma, S.A. Perennial Allergic Rhinitis Drug Product Portfolio Table 100. Faes Farma, S.A. Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Perennial Allergic Rhinitis Drug Distributors List Table 104. Perennial Allergic Rhinitis Drug Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Perennial Allergic Rhinitis Drug Product Image Figure 2. Global Perennial Allergic Rhinitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perennial Allergic Rhinitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Perennial Allergic Rhinitis Drug Sales (2021-2032) & (K Units) Figure 5. Global Perennial Allergic Rhinitis Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Perennial Allergic Rhinitis Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. APC-3000 Image Figure 9. Bilastine Image Figure 10. Desloratadine Image Figure 11. Asapiprant Image Figure 12. Others Image Figure 13. Global Perennial Allergic Rhinitis Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Perennial Allergic Rhinitis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Perennial Allergic Rhinitis Drug Sales Market Share by Type (2021-2032) Figure 16. Global Perennial Allergic Rhinitis Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Perennial Allergic Rhinitis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Others Image Figure 22. Global Perennial Allergic Rhinitis Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Perennial Allergic Rhinitis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Perennial Allergic Rhinitis Drug Sales Market Share by Application (2021-2032) Figure 25. Global Perennial Allergic Rhinitis Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Perennial Allergic Rhinitis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 42. China Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Perennial Allergic Rhinitis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Perennial Allergic Rhinitis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Perennial Allergic Rhinitis Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Perennial Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Perennial Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Perennial Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Perennial Allergic Rhinitis Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Perennial Allergic Rhinitis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • APC-3000
  • Bilastine
  • Desloratadine
  • Asapiprant
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Merck & Co., Inc.
  • Pfizer Inc.
  • VentiRx Pharmaceuticals, Inc.
  • Shionogi & Co., Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Faes Farma, S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Perennial Allergic Rhinitis Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Perennial Allergic Rhinitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Perennial Allergic Rhinitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Perennial Allergic Rhinitis Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Perennial Allergic Rhinitis Drug Market Dynamics
  1. 2.1 Perennial Allergic Rhinitis Drug Industry Trends
  2. 2.2 Perennial Allergic Rhinitis Drug Industry Drivers
  3. 2.3 Perennial Allergic Rhinitis Drug Industry Opportunities and Challenges
  4. 2.4 Perennial Allergic Rhinitis Drug Industry Restraints
3 Perennial Allergic Rhinitis Drug Market by Manufacturers
  1. 3.1 Global Perennial Allergic Rhinitis Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Perennial Allergic Rhinitis Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Perennial Allergic Rhinitis Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Perennial Allergic Rhinitis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Perennial Allergic Rhinitis Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Perennial Allergic Rhinitis Drug Manufacturers, Product Type & Application
  7. 3.7 Global Perennial Allergic Rhinitis Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Perennial Allergic Rhinitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Perennial Allergic Rhinitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Perennial Allergic Rhinitis Drug Tier 1, Tier 2, and Tier 3
4 Perennial Allergic Rhinitis Drug Market by Type
  1. 4.1 Perennial Allergic Rhinitis Drug Type Introduction
  2. 4.1.1 APC-3000
  3. 4.1.2 Bilastine
  4. 4.1.3 Desloratadine
  5. 4.1.4 Asapiprant
  6. 4.1.5 Others
  7. 4.2 Global Perennial Allergic Rhinitis Drug Sales by Type
  8. 4.2.1 Global Perennial Allergic Rhinitis Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Perennial Allergic Rhinitis Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Perennial Allergic Rhinitis Drug Revenue by Type
  12. 4.3.1 Global Perennial Allergic Rhinitis Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Perennial Allergic Rhinitis Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type (2021-2032)
5 Perennial Allergic Rhinitis Drug Market by Application
  1. 5.1 Perennial Allergic Rhinitis Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Perennial Allergic Rhinitis Drug Sales by Application
  6. 5.2.1 Global Perennial Allergic Rhinitis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Perennial Allergic Rhinitis Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Perennial Allergic Rhinitis Drug Revenue by Application
  10. 5.3.1 Global Perennial Allergic Rhinitis Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Perennial Allergic Rhinitis Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application (2021-2032)
6 Global Perennial Allergic Rhinitis Drug Sales by Region
  1. 6.1 Global Perennial Allergic Rhinitis Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Perennial Allergic Rhinitis Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Perennial Allergic Rhinitis Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Perennial Allergic Rhinitis Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Perennial Allergic Rhinitis Drug Revenue by Region
  1. 7.1 Global Perennial Allergic Rhinitis Drug Revenue by Region
  2. 7.1.1 Global Perennial Allergic Rhinitis Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Perennial Allergic Rhinitis Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Perennial Allergic Rhinitis Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Perennial Allergic Rhinitis Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Perennial Allergic Rhinitis Drug Revenue (2021-2032)
  8. 7.2.2 North America Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Perennial Allergic Rhinitis Drug Revenue (2021-2032)
  11. 7.3.2 Europe Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Perennial Allergic Rhinitis Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Perennial Allergic Rhinitis Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Perennial Allergic Rhinitis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck & Co., Inc.
  2. 8.1.1 Merck & Co., Inc. Company Information
  3. 8.1.2 Merck & Co., Inc. Business Overview
  4. 8.1.3 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  6. 8.1.5 Merck & Co., Inc. Recent Developments
  7. 8.2 Pfizer Inc.
  8. 8.2.1 Pfizer Inc. Company Information
  9. 8.2.2 Pfizer Inc. Business Overview
  10. 8.2.3 Pfizer Inc. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  12. 8.2.5 Pfizer Inc. Recent Developments
  13. 8.3 VentiRx Pharmaceuticals, Inc.
  14. 8.3.1 VentiRx Pharmaceuticals, Inc. Company Information
  15. 8.3.2 VentiRx Pharmaceuticals, Inc. Business Overview
  16. 8.3.3 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  18. 8.3.5 VentiRx Pharmaceuticals, Inc. Recent Developments
  19. 8.4 Shionogi & Co., Ltd.
  20. 8.4.1 Shionogi & Co., Ltd. Company Information
  21. 8.4.2 Shionogi & Co., Ltd. Business Overview
  22. 8.4.3 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Product Portfolio
  24. 8.4.5 Shionogi & Co., Ltd. Recent Developments
  25. 8.5 Hisamitsu Pharmaceutical Co., Inc.
  26. 8.5.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
  27. 8.5.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
  28. 8.5.3 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio
  30. 8.5.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments
  31. 8.6 Glenmark Pharmaceuticals Ltd.
  32. 8.6.1 Glenmark Pharmaceuticals Ltd. Company Information
  33. 8.6.2 Glenmark Pharmaceuticals Ltd. Business Overview
  34. 8.6.3 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Product Portfolio
  36. 8.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
  37. 8.7 Faes Farma, S.A.
  38. 8.7.1 Faes Farma, S.A. Company Information
  39. 8.7.2 Faes Farma, S.A. Business Overview
  40. 8.7.3 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Product Portfolio
  42. 8.7.5 Faes Farma, S.A. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Perennial Allergic Rhinitis Drug Value Chain Analysis
  2. 9.1.1 Perennial Allergic Rhinitis Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Perennial Allergic Rhinitis Drug Production Mode & Process
  6. 9.2 Perennial Allergic Rhinitis Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Perennial Allergic Rhinitis Drug Distributors
  9. 9.2.3 Perennial Allergic Rhinitis Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst